medications
- Stock Market
Here’s one thing that will cost less next year—what it means for Medicare beneficiaries
This article is reprinted by permission from NerdWallet. While inflation is pushing up prices for almost everything else, Medicare is…
Read More » - Stock Market
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and Biogen Inc. said their experimental…
Read More » - Stock Market
Alzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug significantly slowed progression of the memory-robbing disease in a large…
Read More » - Stock Market
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for…
Read More » - Stock Market
Moderna expects the shortage of its updated COVID-19 booster to soon be resolved
Moderna Inc. MRNA, -3.04% said Wednesday that it expects to resolve supply issues for its new COVID-19 booster “in the…
Read More » - Stock Market
Can nasal vaccines help prevent COVID-19 infections—or transmission?
The news earlier this week that China and India plan to roll out nasal vaccines underscores the fact that better…
Read More » - Stock Market
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
Moderna Inc. on Friday filed lawsuits against Pfizer Inc. and German partner BioNTech SE, alleging the pair infringed patents relating…
Read More » - Stock Market
What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
Get ready for a big change in how the U.S. will pay for COVID-19 vaccines and treatments. The Department of…
Read More » - Stock Market
U.K. regulator is first to authorize Moderna’s bivalent COVID booster for 18-and-older population
The U.K. regulator has become the first to authorize Moderna’s bivalent COVID vaccine booster for use in adults aged 18…
Read More » - Stock Market
California man charged with naming phony film studio Desilu after famed ‘I Love Lucy’ production company to swindle investors
It was nothing to sneeze at. A man who co-created the cold remedy, Zicam, has been charged with running a…
Read More »